Surmodics (SRDX)
(Delayed Data from NSDQ)
$38.20 USD
-0.17 (-0.44%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $38.21 +0.01 (0.03%) 4:56 PM ET
2-Buy of 5 2
C Value B Growth B Momentum B VGM
SurModics (SRDX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$43.00 | $43.00 | $43.00 | 12.07% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for SurModics comes to $43.00. The forecasts range from a low of $43.00 to a high of $43.00. The average price target represents an increase of 12.07% from the last closing price of $38.37.
Analyst Price Targets (3 )
Broker Rating
SurModics currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, one is Strong Buy, representing 25% of all recommendations. A month ago, Strong Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/30/2024 | Barrington Research | Michael J Petusky | Strong Buy | Hold |
5/29/2024 | Not Identified | Not Identified | Not Available | Hold |
5/29/2024 | Lake Street Capital Markets | Brooks G O'Neil | Not Available | Strong Buy |
5/29/2024 | Needham & Company | Michael Matson | Moderate Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 4 |
Average Target Price | $43.00 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 49 of 252 |
Current Quarter EPS Est: | -0.27 |
SRDX FAQs
Surmodics, Inc. (SRDX) currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Surmodics, Inc. (SRDX) is $43.00. The current on short-term price targets is based on 2 reports.
The forecasts for Surmodics, Inc. (SRDX) range from a low of $43 to a high of $43. The average price target represents a increase of $12.07 from the last closing price of $38.37.
The current UPSIDE for Surmodics, Inc. (SRDX) is 12.07%
Based on short-term price targets offered by three analysts, the average price target for SurModics comes to $43.00. The forecasts range from a low of $43.00 to a high of $43.00. The average price target represents an increase of 12.07% from the last closing price of $38.37.